Literature DB >> 26977884

PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion.

Nils Halberg1, Caitlin A Sengelaub2, Kristina Navrazhina2, Henrik Molina2, Kunihiro Uryu2, Sohail F Tavazoie3.   

Abstract

Enhanced secretion of tumorigenic effector proteins is a feature of malignant cells. The molecular mechanisms underlying this feature are poorly defined. We identify PITPNC1 as a gene amplified in a large fraction of human breast cancer and overexpressed in metastatic breast, melanoma, and colon cancers. Biochemical, molecular, and cell-biological studies reveal that PITPNC1 promotes malignant secretion by binding Golgi-resident PI4P and localizing RAB1B to the Golgi. RAB1B localization to the Golgi allows for the recruitment of GOLPH3, which facilitates Golgi extension and enhanced vesicular release. PITPNC1-mediated vesicular release drives metastasis by increasing the secretion of pro-invasive and pro-angiogenic mediators HTRA1, MMP1, FAM3C, PDGFA, and ADAM10. We establish PITPNC1 as a PI4P-binding protein that enhances vesicular secretion capacity in malignancy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26977884      PMCID: PMC5300038          DOI: 10.1016/j.ccell.2016.02.013

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  45 in total

Review 1.  Morphodynamics of the secretory pathway.

Authors:  François Képès; Alain Rambourg; Béatrice Satiat-Jeunemaître
Journal:  Int Rev Cytol       Date:  2005

2.  ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells.

Authors:  Thomas Waerner; Memetcan Alacakaptan; Ido Tamir; Rupert Oberauer; Annamaria Gal; Thomas Brabletz; Martin Schreiber; Martin Jechlinger; Hartmut Beug
Journal:  Cancer Cell       Date:  2006-09       Impact factor: 31.743

3.  Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.

Authors:  Zhaolei Zeng; Huanxin Lin; Xiaohui Zhao; Guanglin Liu; Xi Wang; Ruihua Xu; Kun Chen; Jun Li; Libing Song
Journal:  Clin Cancer Res       Date:  2012-06-06       Impact factor: 12.531

Review 4.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

Review 5.  Molecular basis of metastasis.

Authors:  Anne C Chiang; Joan Massagué
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

6.  Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P(2).

Authors:  Gerald R V Hammond; Giampietro Schiavo; Robin F Irvine
Journal:  Biochem J       Date:  2009-07-29       Impact factor: 3.857

7.  Cloning and characterization of a novel variant (mM-rdgBbeta1) of mouse M-rdgBs, mammalian homologs of Drosophila retinal degeneration B gene proteins, and its mRNA localization in mouse brain in comparison with other M-rdgBs.

Authors:  Nobuo Takano; Yuji Owada; Ryoji Suzuki; Hiroyuki Sakagami; Tooru Shimosegawa; Hisatake Kondo
Journal:  J Neurochem       Date:  2003-02       Impact factor: 5.372

8.  Analysis of GTPase-activating proteins: Rab1 and Rab43 are key Rabs required to maintain a functional Golgi complex in human cells.

Authors:  Alexander K Haas; Shin-ichiro Yoshimura; David J Stephens; Christian Preisinger; Evelyn Fuchs; Francis A Barr
Journal:  J Cell Sci       Date:  2007-08-07       Impact factor: 5.285

Review 9.  Targeting the PDGF signaling pathway in tumor treatment.

Authors:  Carl-Henrik Heldin
Journal:  Cell Commun Signal       Date:  2013-12-20       Impact factor: 5.712

10.  PITPs as targets for selectively interfering with phosphoinositide signaling in cells.

Authors:  Aaron H Nile; Ashutosh Tripathi; Peihua Yuan; Carl J Mousley; Sundari Suresh; Iain M Wallace; Sweety D Shah; Denise Teotico Pohlhaus; Brenda Temple; Corey Nislow; Guri Giaever; Alexander Tropsha; Ronald W Davis; Robert P St Onge; Vytas A Bankaitis
Journal:  Nat Chem Biol       Date:  2013-11-24       Impact factor: 15.040

View more
  55 in total

Review 1.  The interface between phosphatidylinositol transfer protein function and phosphoinositide signaling in higher eukaryotes.

Authors:  Aby Grabon; Vytas A Bankaitis; Mark I McDermott
Journal:  J Lipid Res       Date:  2018-11-30       Impact factor: 5.922

Review 2.  Proteomics Identifies Golgi phosphoprotein 3 (GOLPH3) with A Link Between Golgi Structure, Cancer, DNA Damage and Protection from Cell Death.

Authors:  John J M Bergeron; Catherine E Au; David Y Thomas; Louis Hermo
Journal:  Mol Cell Proteomics       Date:  2017-09-27       Impact factor: 5.911

Review 3.  GOLPH3: a Golgi phosphatidylinositol(4)phosphate effector that directs vesicle trafficking and drives cancer.

Authors:  Ramya S Kuna; Seth J Field
Journal:  J Lipid Res       Date:  2018-09-28       Impact factor: 5.922

4.  The interleukin-like epithelial-mesenchymal transition inducer ILEI exhibits a non-interleukin-like fold and is active as a domain-swapped dimer.

Authors:  Anna M Jansson; Agnes Csiszar; Joachim Maier; Ann-Christin Nyström; Elisabeth Ax; Patrik Johansson; Lovisa Holmberg Schiavone
Journal:  J Biol Chem       Date:  2017-07-27       Impact factor: 5.157

Review 5.  Emerging themes of regulation at the Golgi.

Authors:  Stefanie L Makowski; Thuy Tt Tran; Seth J Field
Journal:  Curr Opin Cell Biol       Date:  2017-02-16       Impact factor: 8.382

Review 6.  MYO18A: An unusual myosin.

Authors:  Matthew D Buschman; Seth J Field
Journal:  Adv Biol Regul       Date:  2017-09-18

Review 7.  Consequences of Rab GTPase dysfunction in genetic or acquired human diseases.

Authors:  Marcellus J Banworth; Guangpu Li
Journal:  Small GTPases       Date:  2017-12-28

Review 8.  Unlocking Golgi: Why Does Morphology Matter?

Authors:  A Petrosyan
Journal:  Biochemistry (Mosc)       Date:  2019-12       Impact factor: 2.487

Review 9.  TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1.

Authors:  Breege V Howley; Philip H Howe
Journal:  Cytokine       Date:  2018-02-01       Impact factor: 3.861

10.  Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer.

Authors:  Sameer S Bajikar; Chun-Chao Wang; Michael A Borten; Elizabeth J Pereira; Kristen A Atkins; Kevin A Janes
Journal:  Dev Cell       Date:  2017-11-20       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.